SEOVF (Sernova Biotherapeutics) Capex-to-Operating-Income : 0.00 (As of Jan. 2025)

Sernova Biotherapeutics Capex-to-Operating-Income Chart

Sernova Biotherapeutics Annual Data
	Trend	Oct15	Oct16	Oct17	Oct18	Oct19	Oct20	Oct21	Oct22	Oct23	Oct24
Capex-to-Operating-Income		Get a 7-Day Free Trial					-	-	-	-	-

Sernova Biotherapeutics Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Capex-to-Operating-Income	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Sernova Biotherapeutics's Capex-to-Operating-Income

For the Biotechnology subindustry, Sernova Biotherapeutics's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sernova Biotherapeutics's Capex-to-Operating-Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sernova Biotherapeutics's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Sernova Biotherapeutics's Capex-to-Operating-Income falls into.

Sernova Biotherapeutics Capex-to-Operating-Income Calculation

Sernova Biotherapeutics's Capex-to-Operating-Income for the fiscal year that ended in Oct. 2024 is calculated as

Sernova Biotherapeutics's Capex-to-Operating-Income for the quarter that ended in Jan. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sernova Biotherapeutics  (OTCPK:SEOVF) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.

Sernova Biotherapeutics Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Sernova Biotherapeutics's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Sernova Biotherapeutics Business Description